{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:35:46Z","timestamp":1790634946577,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","progcardvascdis.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.pcad.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T17:30:20Z","timestamp":1481909420000},"page":"636-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The Cardio-Renal Interrelationship"],"prefix":"10.1016","volume":"59","author":[{"given":"Konstantinos Dean","family":"Boudoulas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Triposkiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harisios","family":"Boudoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2016.12.003_bb0005","series-title":"Cardiorenal Disorders and Diseases. Second Edition Revised and Expanded","year":"1992"},{"key":"10.1016\/j.pcad.2016.12.003_bb0010","series-title":"Cardiovascular Physiology Concepts","year":"2011"},{"key":"10.1016\/j.pcad.2016.12.003_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000334407","article-title":"Cardiorenal interrelationship","volume":"120","author":"Boudoulas","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2016.12.003_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000360935","article-title":"The left atrium: from the research laboratory to the clinic","volume":"129","author":"Boudoulas","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2016.12.003_bb0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0030","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ejhf.645","article-title":"Global left atrial failure in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.2.2761.1417","article-title":"Paroxysmal dyspnea in cardiorenal patients: with particular reference to cardiac and uremic asthma","volume":"29","author":"Lewis","year":"1913","journal-title":"Br Med J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0195-668X(02)00526-2","article-title":"Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial","volume":"24","author":"Hillege","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ckj\/sfu050","article-title":"Central vasopressin: dendritic and axonal secretion and renal actions","volume":"7","author":"Bichet","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0050","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/eurheartj\/ehv087","article-title":"The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction","volume":"36","author":"Floras","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2362.2003.01222.x","article-title":"Mechanisms of renal hyporesponsiveness to ANP in heart failure","volume":"33","author":"Charloux","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pcad.2016.12.003_bb0060","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.jacc.2015.04.024","article-title":"Cardio-pulmonary-renal interactions","volume":"65","author":"Husain-Syed","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0065","first-page":"977","article-title":"Amino-terminal pro-B-type NP for diagnosis and prognosis in patients with renal dysfunction: a systematic review and meta-analysis","volume":"3","author":"Schaub","year":"2015","journal-title":"JACC HF"},{"key":"10.1016\/j.pcad.2016.12.003_bb0070","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1161\/CIRCULATIONAHA.111.047266","article-title":"Renal function after catheter ablation of atrial fibrillation","volume":"124","author":"Takahashi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0075","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jcin.2015.02.014","article-title":"Atrial remodeling following catheter-based renal denervation occurs in a blood pressure \u2013and heart rate-independent manner","volume":"8","author":"Schrirmer","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.pcad.2016.12.003_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1388-9842(01)00232-X","article-title":"Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure","volume":"4","author":"Van den Berg","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0090","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2016.02.058","article-title":"Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure","volume":"67","author":"Hanberg","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0095","first-page":"751","article-title":"Competing risk of cardiac status and renal function during hospitalization for acute decompensated heart failure","volume":"3","author":"Salah","year":"2015","journal-title":"J Am Coll Cardiol Heart Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"CKD. Effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0105","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0110","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMra0902710","article-title":"Hemodialysis","volume":"363","author":"Himmerlfarb","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0115","series-title":"The Aorta: Structure, Function, Dysfunction, and Diseases","year":"2009"},{"key":"10.1016\/j.pcad.2016.12.003_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000336147","article-title":"Aortic function: from the research laboratory to the clinic","volume":"121","author":"Boudoulas","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2016.12.003_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1523-1755.2005.00086.x","article-title":"Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients","volume":"67","author":"Aoki","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2016.12.003_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0135","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2015.12.052","article-title":"Echocardiography criteria for structural heart disease in patients with end-stage renal disease initiating hemodialysis","volume":"67","author":"Hickson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0140","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","article-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies","volume":"15","author":"Weiner","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000335066","article-title":"Association of mild to moderate kidney dysfunction with coronary artery calcification in patients with suspected coronary artery disease","volume":"120","author":"Cao","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2016.12.003_bb0150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.pcad.2016.12.003_bb0155","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1161\/CIRCULATIONAHA.111.083568","article-title":"Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease","volume":"126","author":"Charytan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0160","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0165","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jacc.2012.12.061","article-title":"Prevalence and prognosis of resistant hypertension in chronic kidney disease patients","volume":"61","author":"De Nicola","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0170","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2015.03.577","article-title":"Changes in renal function in patients with atrial fibrillation","volume":"65","author":"Bohm","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0175","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease","volume":"64","author":"Bonde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0180","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with incidence of atrial fibrillation. The atherosclerosis risk in communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.123992","article-title":"Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease","volume":"127","author":"Bansal","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2013.01.103","article-title":"Candidate gene association study of coronary artery calcification in chronic kidney disease","volume":"62","author":"Ferguson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0195","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/eurheartj\/eht481","article-title":"Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the chronic renal insufficiency cohort study","volume":"35","author":"Mehta","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-011-9291-x","article-title":"The cardiorenal syndrome I HF: cardiac? Renal? Syndrome?","volume":"17","author":"Triposkiadis","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pcad.2016.12.003_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jchf.2015.11.013","article-title":"Inflammation in HF with preserved ejection fraction","volume":"4","author":"Gomberg-Maitland","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jacc.2016.01.045","article-title":"Histamine H2 receptor antagonists, left ventricular morphology, and heart failure risk","volume":"67","author":"Leary","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0220","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1136\/heartjnl-2015-307773","article-title":"Acute kidney injury in patients with acute coronary syndromes","volume":"101","author":"Marenzi","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2016.12.003_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2010.123","article-title":"Cardio-kidney damage: a unifying concept","volume":"78","author":"El Nahas","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2016.12.003_bb0230","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2015.6753","article-title":"CKD in older people","volume":"314","author":"Levey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2016.12.003_bb0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2015.6731","article-title":"An age-calibrated classification of chronic kidney disease","volume":"314","author":"Glassock","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2016.12.003_bb0240","doi-asserted-by":"crossref","first-page":"e003192","DOI":"10.1161\/JAHA.116.003192","article-title":"Relationship of the American Heart Association's impact goals (life's simple 7) with risk of chronic kidney disease: results from the atherosclerosis risk in communities (ARIC) cohort study","volume":"5","author":"Rebholz","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2016.12.003_bb0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/1358863X10382946","article-title":"The cardiovascular continuum extended: aging effects of the aorta and microvasculature","volume":"15","author":"O\u2019Rourke","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1323","article-title":"Metabolically healthy obesity and development of chronic kidney disease: a cohort study","volume":"64","author":"Chang","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0255","author":"National Heart, Lung, Blood Institute: NHLBI Working Group"},{"key":"10.1016\/j.pcad.2016.12.003_bb0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000353261","article-title":"The cardiorenal syndrome: what the cardiologist needs to know","volume":"126","author":"Waldrum","year":"2013","journal-title":"Cardiology"},{"issue":"suppl 1","key":"10.1016\/j.pcad.2016.12.003_bb0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2011.4","article-title":"The complexity of the cardio-renal link: taxonomy, syndromes, and disease","author":"Zoccali","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2016.12.003_bb0270","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabets","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ki.2015.25","article-title":"A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation","volume":"88","author":"Dusseux","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2016.12.003_bb0280","first-page":"2927","article-title":"Biomarkers and heart disease","volume":"19","author":"Sun","year":"2014","journal-title":"Eur Med Pharmacol Sci"},{"key":"10.1016\/j.pcad.2016.12.003_bb0285","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.kint.2016.02.009","article-title":"Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chroniv kidney disease","volume":"89","author":"Ivyatt","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2016.12.003_bb0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCULATIONAHA.111.023937","article-title":"Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction","volume":"124","author":"Reichlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0295","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.114.014245","article-title":"Optimal cut-off levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction","volume":"131","author":"Twerenbold","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0300","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/M14-0746","article-title":"Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review","volume":"161","author":"Stacy","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0305","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2016.12.003_bb0310","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jacc.2013.03.086","article-title":"Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention","volume":"62","author":"Ohno","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.12.003_bb0320","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jacc.2012.06.015","article-title":"Renal artery calcification and mortality among clinically asymptomatic adults","volume":"60","author":"Rifkin","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0325","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.08.959","article-title":"Effects of renal denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension","volume":"60","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0330","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/M15-1839","article-title":"The effect of erythropoietin-stimulating agents on health-related quality of life in anemia of chronic kidney disease: a systematic review and meta-analysis","volume":"164","author":"Collister","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0335","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2011.05.024","article-title":"Device therapy in heart failure patients with chronic kidney disease","volume":"58","author":"Cannizzaro","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0340","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jacc.2015.08.023","article-title":"Reverse remodeling and prognosis following kidney transplantation in contemporary patients with cardiac dysfunction","volume":"66","author":"Hawwa","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0345","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jacc.2011.09.038","article-title":"Changes in renal function after implantation of continuous-flow left ventricular assist devices","volume":"59","author":"Hasin","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0355","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurheartj\/ehq403","article-title":"Renal function and mortality following cardiac resynchronization therapy","volume":"32","author":"Li","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0360","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0365","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0370","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction","volume":"67","author":"Evans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0375","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jacc.2011.04.041","article-title":"Effect of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"58","author":"Bardve","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0380","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2008.11.003","article-title":"MERIT-HS study group. The influence of renal function on clinical outcome and response to beta-blockade in systolic HF: insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)","volume":"15","author":"Ghali","year":"2009","journal-title":"J Cardiol Fail"},{"key":"10.1016\/j.pcad.2016.12.003_bb0385","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence of treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data","volume":"63","author":"Damman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0390","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.98.25.2849","article-title":"Early improvement of renal hemodynamic reserve in patients with asymptomatic heart failure in restored angiotensin II antagonism","volume":"98","author":"Magri","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0395","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2012.12.034","article-title":"Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease","volume":"61","author":"Erickson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0400","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","article-title":"Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0405","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","article-title":"Effects of fibrates in kidney disease: a systematic review and meta-analysis","volume":"60","author":"Jun","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0410","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0415","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.12.003_bb0420","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jacc.2015.03.551","article-title":"Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients","volume":"65","author":"Silbernagel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0425","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0430","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2011.07.010","article-title":"Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease","volume":"58","author":"Go","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0435","doi-asserted-by":"crossref","first-page":"e001683","DOI":"10.1161\/CIRCINTERVENTIONS.115.001683","article-title":"Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry","volume":"8","author":"Baber","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2016.12.003_bb0440","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2011.06.056","article-title":"Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database","volume":"58","author":"Tsai","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0445","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2015.06.1334","article-title":"Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft surgery","volume":"66","author":"Bangalore","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0450","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehq480","article-title":"Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-center post-marketing surveillance registry","volume":"32","author":"Otsuka","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.12.003_bb0455","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.112.001264","article-title":"Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States","volume":"127","author":"Shroff","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2016.12.003_bb0460","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2011.08.051","article-title":"Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease","volume":"58","author":"Barsa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2016.12.003_bb0465","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/CIRCRESAHA.113.301100","article-title":"National Heart, Lung, and Blood Instituteand the translation of cardiovascular discoveries into therapeutic approaches","volume":"112","author":"Galis","year":"2013","journal-title":"Circ Res"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062016301402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062016301402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:30:51Z","timestamp":1568637051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062016301402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0033062016301402"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2016.12.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cardio-Renal Interrelationship","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}